Genitourinary Cancer
Latest News
Cardiorespiratory Fitness May Cut Prostate Cancer Risk
The association between change in absolute CRF and prostate cancer incidence was significant only for participants with a moderate baseline...
Conference Coverage
Small PFS gain in metastatic prostate cancer with TKI and ICI
Expert questions the choice of an androgen receptor pathway inhibitor (ARPI) switch as the control arm of the study.
Conference Coverage
Combo Tx Best in Metastatic Prostate Cancer with HRR Mutations
PFS was better with abiraterone/prednisone and olaparib vs. monotherapy in men with metastatic castration-resistant prostate cancer with DNA...
From the Journals
More Side Effects With Local Therapies for Prostate Cancer
What impact does local therapy have on the men’s quality of life?
Latest News
New Guidelines: Start PSA Screening Earlier in Black Men
Baseline PSA testing in Black men should begin at age 40-45, and should be followed by regular screening intervals, preferably annually.
Conference Coverage
Stockholm3 Prostate Test Bests PSA for Prostate Cancer Risk in North America
The Stockholm3 blood test, using a multiplex algorithm, shows benefits over PSA in a diverse, multi-ethnic cohort beyond a Swedish population...
Conference Coverage
ctDNA Clearance Improves Prediction of Relapse Risk in Urothelial Cancer
The combination of ctDNA with other biomarkers shows further benefits in predicting treatment response.
Conference Coverage
High-dose RT and long-term ADT improve survival in high-risk prostate cancer
These results are “practice-affirming for many,” according to an expert commenting on the new findings.
Feature
Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid Allegations
Dana-Farber Cancer Institute retracts six papers and corrects more than 30 after data changes found.
From the Journals
Functional Outcomes in Localized Prostate Cancer: Treatment Choice, Time, Prognosis All Matter
New study sheds light on quality of life effects related to disease severity and treatment choice.
From the Journals
Prostate Risks Similar for Testosterone Therapy and Placebo
Uncertainty and concern exist about a link between prostate cancer risk and testosterone levels.